Correspondingly, we showed that the inhibition of ERK1/2 activity with PD98059 largely abrogated autocrine hGH-stimulated cell proliferation, survival, invasion and migration of CRC cells. This evidence concerns the gene MAPK3 and colorectal carcinoma.